- Home
- NCPL vs SINT Comparison
NCPL vs SINT Comparison
Compare NCPL & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCPL
- SINT
- Stock Information
- Founded
- NCPL 1984
- SINT 1996
- Country
- NCPL United States
- SINT United States
- Employees
- NCPL N/A
- SINT N/A
- Industry
- NCPL Investment Managers
- SINT Medical/Dental Instruments
- Sector
- NCPL Finance
- SINT Health Care
- Exchange
- NCPL Nasdaq
- SINT Nasdaq
- Market Cap
- NCPL 3.9M
- SINT 4.3M
- IPO Year
- NCPL N/A
- SINT 2014
- Fundamental
- Price
- NCPL $2.07
- SINT $3.10
- Analyst Decision
- NCPL
- SINT Hold
- Analyst Count
- NCPL 0
- SINT 1
- Target Price
- NCPL N/A
- SINT N/A
- AVG Volume (30 Days)
- NCPL 116.3K
- SINT 32.1K
- Earning Date
- NCPL 03-17-2025
- SINT 03-26-2025
- Dividend Yield
- NCPL N/A
- SINT N/A
- EPS Growth
- NCPL N/A
- SINT N/A
- EPS
- NCPL N/A
- SINT N/A
- Revenue
- NCPL $1,702,723.00
- SINT $3,247,000.00
- Revenue This Year
- NCPL N/A
- SINT $18.23
- Revenue Next Year
- NCPL $101.16
- SINT N/A
- P/E Ratio
- NCPL N/A
- SINT N/A
- Revenue Growth
- NCPL N/A
- SINT 30.40
- 52 Week Low
- NCPL $1.41
- SINT $2.01
- 52 Week High
- NCPL $22.82
- SINT $46.00
- Technical
- Relative Strength Index (RSI)
- NCPL 57.35
- SINT 42.35
- Support Level
- NCPL $1.99
- SINT $2.95
- Resistance Level
- NCPL $2.12
- SINT $3.26
- Average True Range (ATR)
- NCPL 0.11
- SINT 0.22
- MACD
- NCPL 0.02
- SINT -0.01
- Stochastic Oscillator
- NCPL 89.19
- SINT 33.33
About NCPL Netcapital Inc.
Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.
About SINT SiNtx Technologies Inc.
SINTX Technologies Inc is an advanced ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing primarily on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming an advanced ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have superb bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.